Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Red Flags for Gilead Sciences' Future

TheMotleyFool

0 0

2 Red Flags for Gilead Sciences' FuturePhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

It hasn't been a great year for biotech giant Gilead Sciences (NASDAQ: GILD). The company's shares are down by 15% since the year started, which is more or less in line with the bad performance of the broader market.

It would be easy to pin the biotech's recent struggles on the volatile geopolitical environment and the various economic issues we're facing. Unfortunately, there are company-specific headwinds investors should worry about too.

Let's consider two of these red flags and whether it's worth purchasing shares of Gilead Sciences anyway.

Source Fool.com

Like: 0

GILD

Share